Skip to content

Role of Individualised Homoeopathic Medicine in Chronic Rhinosinusitis.

Comparative Effectiveness of Individualised Homoeopathic medicine in Centesimal and 50 Millesimal Potency in the treatment of patients with Chronic Rhinosinusitis: An open label Prospective Randomised Controlled Trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096875
Enrollment
136
Registered
2025-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Individualised Homoeopathic Medicine in Centesimal potency: Medicine will be Prescribed in Centesimal potency according to Homoeopathic Principles regarding Dose, Potency, Repetition. I

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants in age group between 18-60 years. Participants belonging to all gender, all religion and all socio-economic status. Participants having Chronic Rhinosinusitis, for 12 weeks or more, fulfilling the diagnostic criteria of AAO-HNS Participants who can understand Bengali or Hindi or English; capable of filling the questionnaire. Participants who are willing to participate in the study and giving informed written consent.

Exclusion criteria

Exclusion criteria: Participants diagnosed with nasal polyps and the complications (mucous retention cyst, orbital cellulitis, meningitis, brain abscess etc.) of CRS. Diagnosed cases of unstable psychiatric illness or some uncontrolled systemic diseases (like DM, Cancer and Thyroid diseases etc.), uncontrolled infections or any vital organ failure or immune-compromised patients. Pregnant and lactating Women. Substance abuse and or dependence or taking psychotropic drugs of modern medicine. Participants who require surgical intervention for Chronic Rhinosinusitis.

Design outcomes

Primary

MeasureTime frame
SNOT-22 scoreTimepoint: At baseline and 4 months.

Secondary

MeasureTime frame
EQ-5D-5L score, MONARCH Score.Timepoint: At baseline and 4 months.

Countries

India

Contacts

Public ContactDr SWAPAN PAUL

National Institute of Homoeopathy

drspaul.2007@gmail.com9830148968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026